Published in Eur J Biochem on April 01, 1985
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature (2009) 8.99
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
Applications of cellular fatty acid analysis. Clin Microbiol Rev (1991) 2.72
Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun (1988) 2.23
Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J (1993) 2.15
TLR-based immune adjuvants. Vaccine (2010) 2.10
The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun (1995) 1.94
Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med (2002) 1.93
Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78
Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun (1992) 1.71
Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun (1992) 1.61
Escherichia coli msbB gene as a virulence factor and a therapeutic target. Infect Immun (1999) 1.59
Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect Immun (2004) 1.59
Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun (1990) 1.54
Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria. PLoS Pathog (2006) 1.49
The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun (1987) 1.49
Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun (2002) 1.40
Chemical, biological, and immunochemical properties of the Chlamydia psittaci lipopolysaccharide. Infect Immun (1986) 1.38
Structure and reactivity of LpxD, the N-acyltransferase of lipid A biosynthesis. Proc Natl Acad Sci U S A (2007) 1.34
Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect Immun (2004) 1.33
Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med (1993) 1.22
The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest (1996) 1.19
MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A. Infect Immun (2002) 1.19
Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis. Infect Immun (2008) 1.16
Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate. Infect Immun (1986) 1.16
The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-kappaB through human toll-like receptor 4. Infect Immun (2002) 1.14
Cyanobacterial lipopolysaccharides and human health - a review. Environ Health (2006) 1.12
Use of synthetic antigens to determine the epitope specificities of monoclonal antibodies against the 3-deoxy-D-manno-octulosonate region of bacterial lipopolysaccharide. Infect Immun (1987) 1.11
Molecular adjuvants and immunomodulators: new approaches to immunization. Clin Microbiol Rev (1994) 1.09
Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. Immunol Lett (2008) 1.08
Modulation of innate immune responses with synthetic lipid A derivatives. J Am Chem Soc (2007) 1.05
Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother (1999) 1.05
A 28,000-dalton protein of normal mouse serum binds specifically to the inner core region of bacterial lipopolysaccharide. Infect Immun (1985) 1.04
Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A. Infect Immun (1987) 1.03
Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity. Front Immunol (2013) 1.03
Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype. Infect Immun (1989) 1.02
Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs. Infect Immun (1995) 1.00
Synthetic Salmonella-type lipid A antigen with high serological specificity. Infect Immun (1986) 0.99
Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence. Infect Immun (2005) 0.98
Differential induction of innate immune responses by synthetic lipid a derivatives. J Biol Chem (2010) 0.97
Anti-endotoxin agents. 1. Development of a fluorescent probe displacement method optimized for the rapid identification of lipopolysaccharide-binding agents. Comb Chem High Throughput Screen (2004) 0.97
Immunogenicity and antigenicity of synthetic Escherichia coli lipid A. Infect Immun (1986) 0.96
The nucleotide-binding site of Aquifex aeolicus LpxC. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.96
Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide. Infect Immun (1999) 0.96
Acyltransferases in bacteria. Microbiol Mol Biol Rev (2013) 0.96
Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide. Infect Immun (1992) 0.94
Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity. Infect Immun (1992) 0.92
Immunobiological activities of synthetic lipid A analogs with low endotoxicity. Infect Immun (1986) 0.92
A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats. Infect Immun (1997) 0.90
Cell activation by ligands of the toll-like receptor and interleukin-1 receptor family depends on the function of the large-conductance potassium channel MaxiK in human macrophages. Infect Immun (2006) 0.90
3-Deoxy-D-manno-octulosonic acid (Kdo) hydrolase identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila. J Biol Chem (2010) 0.89
Relationship of structure and biological activity of monosaccharide lipid A analogues to induction of nitric oxide production by murine macrophage RAW264.7 cells. Infect Immun (1998) 0.89
Comparison of lipids A of several Salmonella and Escherichia strains by 252Cf plasma desorption mass spectrometry. J Bacteriol (1993) 0.89
E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide. Br J Pharmacol (1999) 0.88
Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators. Lung (1990) 0.87
Crystallization of R-form lipopolysaccharides from Salmonella minnesota and Escherichia coli. J Bacteriol (1990) 0.87
Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. MBio (2013) 0.86
Anti-endotoxin agents. 2. Pilot high-throughput screening for novel lipopolysaccharide-recognizing motifs in small molecules. Comb Chem High Throughput Screen (2004) 0.85
Macrophage activation by an ornithine-containing lipid or a serine-containing lipid. Infect Immun (1989) 0.85
Chemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates. European J Org Chem (2010) 0.84
Human gammadelta T cell recognition of lipid A is predominately presented by CD1b or CD1c on dendritic cells. Biol Direct (2009) 0.83
Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers. Org Biomol Chem (2014) 0.83
Biophysical characterization of triacyl monosaccharide lipid a partial structures in relation to bioactivity. Biophys J (2002) 0.83
Endotoxic induction of prostaglandin release from macrophages by nontoxic lipid A analogs synthesized chemically. Infect Immun (1990) 0.83
Key structures of bacterial peptidoglycan and lipopolysaccharide triggering the innate immune system of higher animals: chemical synthesis and functional studies. Proc Jpn Acad Ser B Phys Biol Sci (2010) 0.83
Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein. Infect Immun (1995) 0.82
Expression of endotoxic activities by synthetic monosaccharide lipid A analogs with alkyl-branched acyl substituents. Infect Immun (1995) 0.82
Chemical structure of lipid A isolated from Flavobacterium meningosepticum lipopolysaccharide. J Bacteriol (1998) 0.82
Evolving Bacterial Envelopes and Plasticity of TLR2-Dependent Responses: Basic Research and Translational Opportunities. Front Immunol (2013) 0.81
Structure-activity relationships of antimicrobial and lipoteichoic acid-sequestering properties in polyamine sulfonamides. Antimicrob Agents Chemother (2008) 0.81
FtsH-mediated coordination of lipopolysaccharide biosynthesis in Escherichia coli correlates with the growth rate and the alarmone (p)ppGpp. J Bacteriol (2013) 0.81
Polymyxin B inadequately quenches the effects of contaminating lipopolysaccharide on murine dendritic cells. PLoS One (2012) 0.80
The internalization time course of a given lipopolysaccharide chemotype does not correspond to its activation kinetics in monocytes. Infect Immun (1999) 0.80
Lipid A-mediated tolerance and cancer therapy. Adv Exp Med Biol (2010) 0.80
Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages. Clin Vaccine Immunol (2009) 0.80
Chemical synthesis of Burkholderia Lipid A modified with glycosyl phosphodiester-linked 4-amino-4-deoxy-β-L-arabinose and its immunomodulatory potential. Chemistry (2015) 0.80
Somnogenic activities of synthetic lipid A. Infect Immun (1989) 0.80
The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real? Trends Cancer (2015) 0.80
Inactivation of Escherichia coli endotoxin by soft hydrothermal processing. Appl Environ Microbiol (2009) 0.79
Free hydroxyl groups are not required for endotoxic activity of lipid A. Infect Immun (1994) 0.79
Role of inflammatory mediators in lipid A analogue (ONO-4007)-induced vascular permeability change in mouse skin. Br J Pharmacol (2000) 0.79
A nonsubstituted primary hydroxyl group in position 6' of free lipid A is required for binding of lipid A monoclonal antibodies. Infect Immun (1997) 0.78
A comparison of the endotoxin biosynthesis and protein oxidation pathways in the biogenesis of the outer membrane of Escherichia coli and Neisseria meningitidis. Front Cell Infect Microbiol (2012) 0.78
Hypothermic response of mice to ornithine-containing lipids and to endotoxin. Infect Immun (1996) 0.78
Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues. Adv Carbohydr Chem Biochem (2014) 0.77
Elucidation of a novel lipid A α-(1,1)-GalA transferase gene (rgtF) from Mesorhizobium loti: Heterologous expression of rgtF causes Rhizobium etli to synthesize lipid A with α-(1,1)-GalA. Glycobiology (2013) 0.77
Lipopolysaccharides from Commensal and Opportunistic Bacteria: Characterization and Response of the Immune System of the Host Sponge Suberites domuncula. Mar Drugs (2015) 0.77
Lipid A-mediated tolerance and cancer therapy. Adv Exp Med Biol (2009) 0.77
Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis. Br J Cancer (1994) 0.76
Bilayer Properties of Lipid A from Various Gram-Negative Bacteria. Biophys J (2016) 0.76
Local skin response in mice induced by a single intradermal injection of bacterial lipopolysaccharide and lipid A. Infect Immun (1991) 0.76
Construction of Escherichia coli Mutant with Decreased Endotoxic Activity by Modifying Lipid A Structure. Mar Drugs (2015) 0.75
[Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties]. Infection (1987) 0.75
Synergism between muramyl dipeptide and lipopolysaccharide in the inhibition of glycosaminoglycan synthesis in cultured rat costal chondrocytes. Ann Rheum Dis (1993) 0.75
Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents. Infect Immun (1989) 0.75
Biochemical studies on WbcA, a sugar epimerase from Yersinia enterocolitica. Protein Sci (2015) 0.75
The Role of Lipopolysaccharide Structure in Monocyte Activation and Cytokine Secretion. Shock (2016) 0.75
Mitogenic activities of synthetic Escherichia coli lipid A and a synthetic partial structure (tripalmitoyl pentapeptide) of E. coli lipoprotein. Infect Immun (1988) 0.75
Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ Open Gastroenterol (2017) 0.75
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
A new method for the extraction of R lipopolysaccharides. Eur J Biochem (1969) 22.41
Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae. Bacteriol Rev (1966) 13.42
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A (1979) 6.77
Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem (1975) 5.29
The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med (1973) 4.74
Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med (1987) 4.63
Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim Biophys Acta (1972) 4.45
Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides. Eur J Biochem (1972) 4.15
Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem (1971) 4.15
Structural investigations on the 2-keto-3-deoxyoctonate region of lipopolysaccharides. Eur J Biochem (1970) 4.14
Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem (1971) 4.01
The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med (1975) 3.55
Structural relationship of Salmonella O and R antigens. Ann N Y Acad Sci (1966) 3.54
Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res (2001) 3.46
Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun (1986) 3.42
Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A (1979) 3.08
Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem (1972) 3.04
Synthesis and use of O-stearoyl polysaccharides in passive hemagglutination and hemolysis. Eur J Biochem (1967) 2.99
Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component. Eur J Biochem (1969) 2.93
Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91
Electroporation of cell membrane visualized under a pulsed-laser fluorescence microscope. Biophys J (1988) 2.83
Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) (2000) 2.64
IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol (1989) 2.41
Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect Immun (1991) 2.34
A lethal role for lipid A in Salmonella infections. Mol Microbiol (1998) 2.30
Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun (1988) 2.23
A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med (1996) 2.21
[Immunochemical studies of K antigens from Escherichia coli. II. K antigen from E. coli 08:K42(A):H-]. Biochem Z (1965) 2.20
Differential determination of the 3-Deoxy-D-mannooctulosonic acid residues in lipopolysaccharides of Salmonella minnesota rough mutants. Eur J Biochem (1983) 2.12
Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J Immunol (1983) 2.06
Analgesic effect of morphine glucuronides. Tohoku J Exp Med (1971) 2.02
Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J Clin Microbiol (1990) 2.02
Bacterial endotoxins. Sci Am (1992) 2.00
Molecular mechanisms of endotoxin activity. Arch Microbiol (1995) 1.98
Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture. Int Arch Allergy Appl Immunol (1975) 1.97
A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91
Analyis of met-form haemoglobins in human erythrocytes of normal adults and of a patient with hereditary methaemoglobinaemia due to deficiency of NADH-cytochrome b5 reductase. Biochem J (1979) 1.88
Isolation and analysis of the lipid A backbone. Lipid A structure of lipopolysaccharides from various bacterial groups. Eur J Biochem (1976) 1.87
Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog Allergy (1983) 1.86
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem (2000) 1.85
Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut (2007) 1.85
High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol (1985) 1.85
Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun (1980) 1.85
Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol (1996) 1.85
Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res (2000) 1.81
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. Eur J Biochem (1988) 1.73
Lipid A: chemical structure and biological activity. J Infect Dis (1973) 1.73
Diurnal variations in the human host response to endotoxin. J Infect Dis (1996) 1.71
Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften (1978) 1.69
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
B-lymphotropic papovavirus and possibility of infections in humans. J Med Virol (1981) 1.68
The chemical structure of lipid A. Demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide. Eur J Biochem (1982) 1.67
Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest (1997) 1.67
The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity. Eur J Biochem (1976) 1.64
Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun (1992) 1.61
Studies on the structure of lipopolysaccharides of Salmonella minnesota and Salmonella typhimurium R strains. Biochem J (1965) 1.60
Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature (1997) 1.60
Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun (1994) 1.59